SST and Alzheimer disease: Amongst the neuropeptides studied to date, SST is one of the most significant peptides that changes during the onset and progression of AD, with a consistent reduction in both the cerebrospinal fluid and brain tissues of AD patients [52,53,54,55,56,57,58,59].